Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc., a subsidiary of Takeda Pharmaceutical Company, is a prominent player in the biotechnology industry, headquartered in the United States. Founded in 1993, the company has made significant strides in oncology, focusing on innovative therapies for cancer treatment. With a strong presence in North America and Europe, Millennium is renowned for its commitment to advancing cancer care through cutting-edge research and development.
The company’s flagship products, including Velcade and Ninlaro, are distinguished by their unique mechanisms of action, offering new hope to patients with multiple myeloma and other malignancies. Millennium's dedication to scientific excellence has positioned it as a leader in the oncology market, with numerous accolades recognising its contributions to cancer therapeutics. Through its ongoing efforts, Millennium Pharmaceuticals continues to shape the future of cancer treatment, striving to improve patient outcomes worldwide.
+38 vs industry average
Millennium Pharmaceuticals, Inc.’s score of 76 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Millennium Pharmaceuticals, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Millennium Pharmaceuticals, Inc. yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Millennium Pharmaceuticals, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Millennium Pharmaceuticals, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Takeda Pharmaceutical Company Limited
Carbon Disclosure Project
Inherited from Takeda Pharmaceutical Company LimitedThe Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from Takeda Pharmaceutical Company LimitedRE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project